BUY Vedanta Ltd. — Madhu Bansal
byMadhu BansalHorizon: 1–3 months7 Apr 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·16 Apr · today
2 other SEBI-registered advisors have active short-term BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·13 Apr · 2d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Vedanta
- BUY — Rakesh Bansal6 Oct 2026 · Same day · target ₹272 · Expired
- SELL — Vaishali Parekh, Prabhudas Lilladher30 Sept 2026 · ~2 weeks · target ₹240 · Expired
- BUY — Rakesh Bansal23 Sept 2026 · Next day · target ₹275 · SL hit
- SELL — Nagaraj Shetty, HDFC Securities17 Sept 2026 · ~3 months · target ₹238 · SL hit
- SELL — Nagaraj Shetty, HDFC Securities16 Sept 2026 · Same day · target ₹245 · Expired
More from Madhu Bansal
- BUY Supriya Lifescience29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY Supreme Petrochem29 Sept 2026 · ~2 weeks · target ₹957 · SL hit
- BUY Poonawalla Fincorp18 Sept 2026 · ~2 weeks · target ₹486 · Target hit
- BUY Prudent Corporate Advisory Services18 Sept 2026 · ~3 months · target ₹3,762 · SL hit
- BUY Sun Pharma Advanced Research Company17 Sept 2026 · ~2 weeks · target ₹208 · Target hit

